Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Infections”

1,946 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,946 results

Testing effectiveness (Phase 2)Study completedNCT00943540
What this trial is testing

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIV Infections
Radboud University Medical Center 20
Early research (Phase 1)Study completedNCT00001020
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Large-scale testing (Phase 3)Active Not RecruitingNCT02881320
What this trial is testing

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

Who this might be right for
HIV-1 Infection
Gilead Sciences 177
Not applicableEnded earlyNCT00709397
What this trial is testing

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

Who this might be right for
HIV-1 Infection
Brigham and Women's Hospital 3
Not applicableStudy completedNCT00665561
What this trial is testing

Prospective Observational Epidemiologic Study of Maraviroc's Safety

Who this might be right for
Human Immunodeficiency Virus
ViiV Healthcare 2,500
Large-scale testing (Phase 3)Study completedNCT00242840
What this trial is testing

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 20
Large-scale testing (Phase 3)UnknownNCT00199979
What this trial is testing

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Who this might be right for
Hiv Infection With Antiretroviral Therapy IndicationCD4 Below 350/µL or Below 15%
MEDEX 250
Testing effectiveness (Phase 2)Study completedNCT02588586
What this trial is testing

The Safety and Antiretroviral Activity of 3BNC117

Who this might be right for
HIV-1 Infection
Rockefeller University 17
Large-scale testing (Phase 3)Study completedNCT02489461
What this trial is testing

Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

Who this might be right for
HIV-1-infection
Viriom 150
Not applicableStudy completedNCT04301661
What this trial is testing

Cellular Pharmacology and Platelet Effects of Abacavir and Lamivudine Anabolites

Who this might be right for
HIV-1-infection
University of Colorado, Denver 25
Not applicableStudy completedNCT01634607
What this trial is testing

Bone Health and Vitamin D Status

Who this might be right for
OsteopeniaVitamin D DeficiencyHIV Infection
Thai Red Cross AIDS Research Centre 235
Not applicableStudy completedNCT00001137
What this trial is testing

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 5,982
Early research (Phase 1)Study completedNCT03875209
What this trial is testing

10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV-1-infection
David Ho 54
Not applicableStudy completedNCT00000892
What this trial is testing

Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT04568395
What this trial is testing

Acute Effects of TCIG vs ECIG in PLWH

Who this might be right for
E Cigarette UseVapingSmoking+6 more
University of California, Los Angeles 37
Early research (Phase 1)Study completedNCT02208167
What this trial is testing

Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy

Who this might be right for
HIV
University of North Carolina, Chapel Hill 6
Large-scale testing (Phase 3)Study completedNCT01448707
What this trial is testing

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Who this might be right for
Human Immunodeficiency Virus (HIV) InfectionsAcquired Immunodeficiency Syndrome (AIDS) Virus
Janssen-Cilag International NV 274
Testing effectiveness (Phase 2)Study completedNCT01138605
What this trial is testing

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

Who this might be right for
HIV-1 Infections
Janssen Sciences Ireland UC 46
Early research (Phase 1)Study completedNCT00090077
What this trial is testing

Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults

Who this might be right for
HIV Infections
GlaxoSmithKline 50
Not applicableUnknownNCT05243381
What this trial is testing

Inflammation, NK Cells, Antisense Protein and Exosomes, and Correlation With Immune Response During HIV Infection

Who this might be right for
HIV Infections
University Hospital, Montpellier 60
Next Page